| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |